Stryker Corporation cash flow to debt ratio of 30.83% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Stryker Corporation's free cash flow has increased 22.83% from $3.49B last year to $4.28B, signaling increasing performance

Stryker Corporation's debt to equity ratio is 0.62, which means that the company's assets are unhealthy financed, signaling financial risk.

Stryker Corporation's debt has decreased relative to shareholder equity from 0.68 last year to 0.62 today, signaling strengthened financials

Stryker Corporation has a net debt to EBITDA ratio of 1.94x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Stryker Corporation's interest coverage ratio of 8.30 indicates that earnings with good margin can cover interest payments on company debt

Stryker Corporation's profit margin has increased (8.96%) in the last year from 13.25% to 14.43%, signaling increasing performance

Stryker Corporation's short-term assets of $14.76B exceed its short-term liabilities of $7.79B

Stryker Corporation's return on assets of 7.78% is higher than the 5.00% threshold, indicating efficient asset utilization

Stryker Corporation's return on equity of 16.36%, is higher than 15.00%, indicating good performance

Stryker Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Stryker Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Stryker Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Stryker Corporation has a free cash flow yield of 3.23%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Stryker Corporation's yearly earnings has increased 8.45% since last year from $2.99B to $3.25B, signaling increasing performance

Stryker Corporation's yearly revenue has increased 11.16% since last year from $22.59B to $25.12B, signaling increasing performance

ROIC 9.82% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Stryker Corporation's 3-year revenue CAGR of 10.83% is positive, indicating growing revenue over the past 3 years

Stryker Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Stryker Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Stryker Corporation is overvalued relative to its fair value price of 161.93 based on Discounted Cash Flow model

Stryker Corporation has an earnings yield of 2.81%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Stryker Corporation is overvalued relative to its fair value price of 87.08 based on EBITDA multiple model

Stryker Corporation has an EV/EBITDA ratio of 22.94x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Stryker Corporation is overvalued relative to its fair value price of 303.09 based on Earnings Fair Value model

Stryker Corporation has a PEG-ratio over 1 which is considered overvalued

Stryker Corporation has a price-to-book ratio of 5.53x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Stryker Corporation has a price-to-sales ratio of 5.13x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue